Financhill
Sell
44

CINT Quote, Financials, Valuation and Earnings

Last price:
$6.22
Seasonality move :
11.61%
Day range:
$6.00 - $6.31
52-week range:
$3.34 - $8.04
Dividend yield:
0%
P/E ratio:
36.91x
P/S ratio:
1.98x
P/B ratio:
2.84x
Volume:
61.6K
Avg. volume:
70.4K
1-year change:
20.66%
Market cap:
$833.8M
Revenue:
$447.5M
EPS (TTM):
$0.17
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $171.8M $187.4M $268.2M $424.3M $447.5M
Revenue Growth (YoY) -- 9.12% 43.12% 58.19% 5.47%
 
Cost of Revenues $113.9M $117.7M $173.8M $276.4M $298.1M
Gross Profit $57.9M $69.7M $94.5M $147.9M $149.4M
Gross Profit Margin 33.69% 37.18% 35.22% 34.85% 33.39%
 
R&D Expenses $3.1M $678.3K $740 -- --
Selling, General & Admin $32M $28.7M $44.8M $93M $93M
Other Inc / (Exp) $1.3M -$686.9K -$4.9M $644.5K $2.5M
Operating Expenses $35M $29M $44.4M $92.8M $92.8M
Operating Income $22.8M $40.7M $50.1M $55M $56.6M
 
Net Interest Expenses $2.4M $2.2M $6.1M $16.9M $17.2M
EBT. Incl. Unusual Items $21.8M $37.8M $39.1M $38.8M $41.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $7.4M $12.8M $15.7M $20.3M $15.4M
Net Income to Company $14.3M $25M $23.4M $18.6M $26.6M
 
Minority Interest in Earnings -$8.9K -- -- -- --
Net Income to Common Excl Extra Items $14.3M $25M $23.4M $18.6M $26.6M
 
Basic EPS (Cont. Ops) $0.11 $0.19 $0.19 $0.14 $0.19
Diluted EPS (Cont. Ops) $0.11 $0.19 $0.19 $0.14 $0.19
Weighted Average Basic Share $132.2M $132.2M $121.8M $133.2M $136.4M
Weighted Average Diluted Share $132.2M $132.2M $125.2M $134.8M $139.1M
 
EBITDA $30.3M $45.6M $53.6M $71.5M $77.3M
EBIT $23.8M $39.8M $44.6M $53.2M $58.7M
 
Revenue (Reported) $171.8M $187.4M $268.2M $424.3M $447.5M
Operating Income (Reported) $22.8M $40.7M $50.1M $55M $56.6M
Operating Income (Adjusted) $23.8M $39.8M $44.6M $53.2M $58.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $45.2M $71.9M $106.7M $108.3M $112.1M
Revenue Growth (YoY) -- 59% 48.28% 1.53% 3.52%
 
Cost of Revenues $28M $47.2M $69.4M $73M $73.3M
Gross Profit $17.2M $24.7M $37.3M $35.3M $38.9M
Gross Profit Margin 38.12% 34.34% 34.95% 32.57% 34.67%
 
R&D Expenses $128.5K -- -- -- --
Selling, General & Admin $6.5M $12.1M $24.5M $21.5M $23.9M
Other Inc / (Exp) $103.2K -$1.9M $2M $254.5K -$1.1M
Operating Expenses $6.5M $16.9M $25M $20.8M $23.8M
Operating Income $10.7M $7.8M $12.3M $14.4M $15.1M
 
Net Interest Expenses $388.2K $2.7M $3.4M $4.6M $3.5M
EBT. Incl. Unusual Items $10.4M $3.2M $10.9M $10.1M $10.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.1M $3.6M $3.2M $4.6M $5.3M
Net Income to Company -- -$227.2K $7M $5.8M $4.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $7.4M -$422.5K $7.7M $5.5M $5.1M
 
Basic EPS (Cont. Ops) $0.06 -$0.00 $0.06 $0.04 $0.04
Diluted EPS (Cont. Ops) $0.06 -$0.00 $0.06 $0.04 $0.04
Weighted Average Basic Share $132.2M $132.2M $133.3M $137.1M $136M
Weighted Average Diluted Share $132.2M $132.2M $133.3M $141.3M $138.9M
 
EBITDA $12.2M $8M $18.9M $19.1M $18.2M
EBIT $10.8M $5.3M $14.4M $14.4M $13.9M
 
Revenue (Reported) $45.2M $71.9M $106.7M $108.3M $112.1M
Operating Income (Reported) $10.7M $7.8M $12.3M $14.4M $15.1M
Operating Income (Adjusted) $10.8M $5.3M $14.4M $14.4M $13.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $291M $389.4M $457.4M $431.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $187M $254.6M $301.4M $286.5M
Gross Profit -- $103.9M $134.8M $156M $145.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $151.6K -- -- --
Selling, General & Admin -- $46.6M $83.1M $93.2M $94.8M
Other Inc / (Exp) $103.2K -$2.2M $1.8M -$2.3M $1.3M
Operating Expenses -- $51.2M $79.9M $91.1M $94.8M
Operating Income -- $52.7M $54.9M $64.9M $50.6M
 
Net Interest Expenses $388.2K $4.2M $15.7M $17.8M $13.5M
EBT. Incl. Unusual Items -- $46.3M $41M $44.7M $38.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $18.1M $14.6M $23M $14.7M
Net Income to Company -- -- $26M $22.7M $22M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- $28.2M $26.5M $21.8M $23.6M
 
Basic EPS (Cont. Ops) -- $0.21 $0.20 $0.21 $0.17
Diluted EPS (Cont. Ops) -- $0.21 $0.20 $0.20 $0.17
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- $57M $70.9M $80.6M $70.5M
EBIT -- $49.9M $54.5M $61.2M $52.8M
 
Revenue (Reported) -- $291M $389.4M $457.4M $431.9M
Operating Income (Reported) -- $52.7M $54.9M $64.9M $50.6M
Operating Income (Adjusted) -- $49.9M $54.5M $61.2M $52.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $45.2M $241.8M $307.6M $341.1M $326.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $28M $156.2M $201.8M $227M $216.1M
Gross Profit $17.2M $85.6M $105.8M $114.1M $110.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $128.5K $1.5K -- -- --
Selling, General & Admin $6.5M $37.6M $67.7M $67.9M $69.8M
Other Inc / (Exp) $103.2K -$2.6M $4.7M $1.6M $96.5K
Operating Expenses $6.5M $41.9M $69.2M $67.5M $69.6M
Operating Income $10.7M $43.7M $36.6M $46.6M $40.8M
 
Net Interest Expenses $388.2K $3.7M $12.9M $13.8M $10M
EBT. Incl. Unusual Items $10.4M $37.4M $28.4M $34.4M $30.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.1M $14.6M $9.8M $12.6M $11.9M
Net Income to Company -- $15.7M $18.3M $22.4M $17.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $7.4M $22.8M $18.6M $21.8M $19M
 
Basic EPS (Cont. Ops) $0.06 $0.17 $0.14 $0.16 $0.14
Diluted EPS (Cont. Ops) $0.06 $0.17 $0.14 $0.16 $0.14
Weighted Average Basic Share $132.2M $396.6M $399M $404.7M $410.2M
Weighted Average Diluted Share $132.2M $396.6M $399.3M $416.7M $419.6M
 
EBITDA $12.2M $46.2M $52.3M $61.4M $54.7M
EBIT $10.8M $40.5M $39.2M $47.3M $41.5M
 
Revenue (Reported) $45.2M $241.8M $307.6M $341.1M $326.4M
Operating Income (Reported) $10.7M $43.7M $36.6M $46.6M $40.8M
Operating Income (Adjusted) $10.8M $40.5M $39.2M $47.3M $41.5M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $19.8M $31.3M $24.4M $35.1M $43.6M
Short Term Investments -- -- $143.3M $18.2M $651.9K
Accounts Receivable, Net $31.9M $37.7M $61.1M $94.9M $97.2M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.4M $2.5M $5.4M $7.2M $5.6M
Total Current Assets $63.4M $83.6M $260.3M $202.6M $187.9M
 
Property Plant And Equipment $25.3M $20.9M $23.6M $21.1M $16.1M
Long-Term Investments -- -- -- -- --
Goodwill $3.6M $2.8M $111.2M $271.9M $287M
Other Intangibles $987.7K $691.7K $21.4M $60.1M $57.1M
Other Long-Term Assets $934.3K $1.1M $1.1M $8.5M $7.7M
Total Assets $101.2M $112.5M $423.9M $567.9M $559.8M
 
Accounts Payable $2.1M $2.9M $14.8M $20.8M $7.2M
Accrued Expenses $21.8M $27.3M $23.9M $11M $10.5M
Current Portion Of Long-Term Debt $5.8M $14.5M $29.5M $44.6M $23.2M
Current Portion Of Capital Lease Obligations $3.5M $2.8M $3.8M $4.1M $3.7M
Other Current Liabilities $13.5M $2.7M $3.9M $9.8M $5.6M
Total Current Liabilities $56.5M $59.8M $98.5M $138M $93.8M
 
Long-Term Debt $1.2M $2.7M $112M $142.5M $126.7M
Capital Leases -- -- -- -- --
Total Liabilities $74M $74.4M $228.4M $320.5M $269M
 
Common Stock $17.1M $13.3M $6.5K $7K $7.6K
Other Common Equity Adj $10.1M $24.9M $31.1M $26.5M $15.7M
Common Equity $27.3M $38.2M $195.5M $247.4M $290.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $27.3M $38.2M $195.5M $247.4M $290.8M
 
Total Liabilities and Equity $101.2M $112.5M $423.9M $567.9M $559.8M
Cash and Short Terms $19.8M $31.3M $167.7M $53.3M $44.3M
Total Debt $6.9M $17.2M $141.5M $187.2M $149.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- $20.9M $28.1M $38.6M $70.5M
Short Term Investments -- -- $33.7M $7.8M --
Accounts Receivable, Net -- $58.8M $85.7M $83.8M $81.9M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- $5.1M $8.6M $7.6M $5.7M
Total Current Assets -- $114.5M $202.1M $198.1M $217.6M
 
Property Plant And Equipment -- $24.2M $24.2M $16.9M $15.5M
Long-Term Investments -- -- -- -- --
Goodwill -- $114.2M $177.4M $279.1M $277.1M
Other Intangibles -- $23.5M $30.7M $56.6M $51.7M
Other Long-Term Assets -- $992.8K $8.6M $8.6M $4.3M
Total Assets -- $282.7M $450.1M $565.9M $570.2M
 
Accounts Payable -- $22.7M $16.8M $11.6M $26.4M
Accrued Expenses -- $39.5M $47.4M $14.3M $14.8M
Current Portion Of Long-Term Debt -- $25.6M $46.8M $44.6M $46.1M
Current Portion Of Capital Lease Obligations -- $3.9M $5.4M $3.8M $3.9M
Other Current Liabilities -- $3.4M $16.8M $13.8M $4.8M
Total Current Liabilities -- $99.9M $138.6M $123.6M $137.9M
 
Long-Term Debt -- $118.8M $84M $123.2M $108M
Capital Leases -- -- -- -- --
Total Liabilities -- $237M $245.3M $281.5M $276.9M
 
Common Stock -- $11M $6.9K $7.4K $6.8K
Other Common Equity Adj -- $34.8M $29.5M $104M $38.4M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $45.8M $204.7M $284.4M $293.4M
 
Total Liabilities and Equity -- $282.7M $450.1M $565.9M $570.2M
Cash and Short Terms -- $20.9M $61.8M $46.4M $70.5M
Total Debt -- $144.4M $130.8M $167.8M $154M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $14.3M $25M $23.4M $18.6M $26.6M
Depreciation & Amoritzation $6.5M $5.9M $9M $18.3M $18.7M
Stock-Based Compensation $804.1K $184.6K $470K $1.1M $5.6M
Change in Accounts Receivable -$9.2M -$10.8M -$31.4M -$36.1M $7.2M
Change in Inventories -- -- -- -- --
Cash From Operations $23.2M $19.8M $24.4M $7M $59.2M
 
Capital Expenditures $5M $4.2M $5.3M $4.5M $4.8M
Cash Acquisitions -- -- -$128.6M -$140.2M --
Cash From Investing -$4.2M -$4.2M -$279.7M -$16M $13.3M
 
Dividends Paid (Ex Special Dividend) -$10.2M -$6.1M -$23.4M -- --
Special Dividend Paid
Long-Term Debt Issued $2.1M $28.3M $137.5M $102.3M $41.1M
Long-Term Debt Repaid -$8.9M -$20.3M -$17.2M -$73.2M -$86.4M
Repurchase of Common Stock -- -- -- -- -$8.7M
Other Financing Activities -- -- -$10.4M -$12M -$13.1M
Cash From Financing -$17.7M $1.1M $255.7M $19.5M -$66.8M
 
Beginning Cash (CF) $19.6M $15.6M $30.2M $26.3M $37.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.3M $16.7M $297.3K $10.5M $5.6M
Ending Cash (CF) $20.2M $31.9M $25.2M $36M $42.4M
 
Levered Free Cash Flow $18.1M $15.6M $19M $2.5M $54.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -$227.2K $7M $5.8M $4.3M
Depreciation & Amoritzation -- $2.7M $3.9M $4.8M $3.8M
Stock-Based Compensation -- $59.1K $130.6K $1.4M $1.8M
Change in Accounts Receivable -- -$13.5M -$2.1M $6.3M -$136.1K
Change in Inventories -- -- -- -- --
Cash From Operations -- $8.4M $18.9M $23.8M $25.4M
 
Capital Expenditures -- $986.5K $686.4K $1.3M $2.4M
Cash Acquisitions -- -$122.8M -$7.1M -- --
Cash From Investing -- -$123.8M -$379.4K -$1.8M -$2.4M
 
Dividends Paid (Ex Special Dividend) -- -$164.5K -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $125M $8.3M $9.8M $9.2M
Long-Term Debt Repaid -- -$1.7M -$4.9M -$19.2M -$8M
Repurchase of Common Stock -- -- -- -$4M -$3.3M
Other Financing Activities -- -- -$11.7M -$294.5K -$873.8K
Cash From Financing -- $123.1M -$8.1M -$13.7M -$2.5M
 
Beginning Cash (CF) -- $15.3M $21.2M $30.1M $50.8M
Foreign Exchange Rate Adjustment -- -$1.6M -$953.4K $727.9K $272.9K
Additions / Reductions -- $7.7M $10.5M $8.4M $20.5M
Ending Cash (CF) -- $21.7M $29M $39.8M $69.1M
 
Levered Free Cash Flow -- $7.4M $18.2M $22.5M $23M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- $26M $22.7M $22M
Depreciation & Amoritzation -- -- $16M $20.1M $16.6M
Stock-Based Compensation -- $132.8K $698.6K $5.2M $5M
Change in Accounts Receivable -- -- -$36.1M $3.1M -$4.1M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- $5.2M $55M $66.6M
 
Capital Expenditures -- $4.2M $4.9M $3.6M $8.9M
Cash Acquisitions -- -$122.8M -$67.2M -$78.7M --
Cash From Investing -- -- -$107.2M -$53.4M -$1.3M
 
Dividends Paid (Ex Special Dividend) -- -$13.6M -$9.8M -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $76.6M $50.1M
Long-Term Debt Repaid -- -- -$58.4M -$53.3M -$65.9M
Repurchase of Common Stock -- -- -- -$7.7M -$10.1M
Other Financing Activities -- -- -- -$8M -$5.8M
Cash From Financing -- -- $112.1M $8.2M -$31M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- $10.1M $9.7M $34.3M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- $258.7K $51.4M $57.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- $15.7M $18.3M $22.4M $17.9M
Depreciation & Amoritzation -- $5.8M $12.8M $14.5M $12.5M
Stock-Based Compensation -- $132.8K $361.4K $4.5M $3.8M
Change in Accounts Receivable -- -$32.2M -$37M $2.3M -$9M
Change in Inventories -- -- -- -- --
Cash From Operations -- $7.5M -$11.6M $36.4M $43.9M
 
Capital Expenditures -- $4.2M $3.8M $3M $7.1M
Cash Acquisitions -- -$122.8M -$61.4M -- --
Cash From Investing -- -$127M $45.5M $8.1M -$6.5M
 
Dividends Paid (Ex Special Dividend) -- -$13.6M -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $141.7M $35.5M $9.8M $18.8M
Long-Term Debt Repaid -- -$16.1M -$57.2M -$37.2M -$16.7M
Repurchase of Common Stock -- -- -- -$7.7M -$9.1M
Other Financing Activities -- -- -$11.8M -$7.8M -$602.6K
Cash From Financing -- $112.1M -$31.5M -$42.9M -$7.1M
 
Beginning Cash (CF) -- $69.4M $72.4M $114.2M $166.3M
Foreign Exchange Rate Adjustment -- -$561.9K $695.9K $140.8K $664.4K
Additions / Reductions -- -$7.4M $2.4M $1.6M $30.3M
Ending Cash (CF) -- $61.3M $75.4M $118.3M $192.7M
 
Levered Free Cash Flow -- $3.3M -$15.5M $33.4M $36.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock